Combination therapy of Evolocumab and LDL apheresis in patients with heterozygous familial hypercholesterolemia: A case series

2017 ◽  
Vol 263 ◽  
pp. e230
Author(s):  
José Carlos Alarcón García ◽  
Aurora González Estrada ◽  
Ana Camacho Carrasco ◽  
Paula García Ocaña ◽  
María Carmen Alarcón Garcelan ◽  
...  
Keyword(s):  
Combination Therapy ◽  
Familial Hypercholesterolemia ◽  
Case Series ◽  
Ldl Apheresis ◽  
Heterozygous Familial Hypercholesterolemia

Treatment of Homozygous and Double Heterozygous Familial Hypercholesterolemia Children with LDL-Apheresis

1995 ◽  
Vol 18 (2) ◽  
pp. 103-110 ◽  
Author(s):  
C. Stefanutti ◽  
A. Vivenzio ◽  
C. Colombo ◽  
S. Di Giacomo ◽  
B. Mazzarella ◽  
...  
Keyword(s):  
Familial Hypercholesterolemia ◽  
Ldl Apheresis ◽  
Heterozygous Familial Hypercholesterolemia

Selective ldl apheresis decreases serum chemerin levels in patients with heterozygous familial hypercholesterolemia

2015 ◽  
Vol 241 (1) ◽  
pp. e205
Author(s):  
M. Harangi ◽  
V.E. Varga ◽  
H. Lorincz ◽  
N. Zsíros ◽  
I. Seres ◽  
...  
Keyword(s):  
Familial Hypercholesterolemia ◽  
Ldl Apheresis ◽  
Heterozygous Familial Hypercholesterolemia
Sign in / Sign up

Export Citation Format

Share Document